Jump to content

20250171520. Compositions (Regeneron Pharmaceuticals, .)

From WikiPatents

COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES

Abstract: compositions and methods for treating enzyme-deficiency diseases are disclosed. multidomain therapeutic proteins containing an internalization effector binding domain and a lysosomal replacement enzyme activity are disclosed. the multidomain therapeutic proteins are capable of entering cells, segregating to the lysosome, and delivering the replacement enzyme activity to the lysosome.

Inventor(s): Andrew Baik, Katherine Cygnar, Christopher Schoenherr, Christos Kyratsous, Cheng Wang

CPC Classification: C07K14/70596 (PEPTIDES (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))

Search for rejections for patent application number 20250171520


Cookies help us deliver our services. By using our services, you agree to our use of cookies.